EMA Probes Novartis MS Pill Over Deaths
One month after Novartis initiated an investigation into a death tied to its new Gilenya pill for multiple sclerosis, the European Medicines Agency has now launched its own probe after receiving reports of up to 11 deaths among patients who took the medication. This includes the first death that the drugmaker reported initially (here is […]
Read More »Category : News
Novo Must Get Rid Of Paula Deen: Kliff Explains
Earlier this week, Paula Deen, the self-styled ‘Queen of Southern Cuisine’ and Food Network star, disclosed that she not only had Type 2 diabetes for the past three years, but had just signed up as a paid spokesperson for Novo Nordisk, which sells various diabetes treatments (back story). The reaction was fast and furious – […]
Read More »Category : News
FDA warns J&J’s DePuy for selling unapproved device components
Johnson & Johnson (NYSE:JNJ) subsidiary DePuy Orthopaedics finds itself in the FDA spotlight, according to a warning letter released by the agency’s Centers for Devices & Radiological Health this week. The watchdog agency detailed more than a dozen devices or device components it said lacked proper PMA clearance or which were modified in ways that […]
Read More »Category : News
The Controversial Death Of A Sanofi Sales Rep
Early on a Sunday morning in July 2010, a Sanofi sales rep named Kang was driving a medical school professor to a planned golf outing in South Korea. But then, tragedy struck. An accident ensued and Kang was killed; the professor was harmed, but survived. The Kang estate later maintained this was a work-related death […]
Read More »Category : News
J&J Hid 3 Risperdal Diabetes Studies From FDA, Texas Jury Told
Johnson & Johnson officials hid three studies showing some patients using Risperdal developed diabetes while claiming the antipsychotic drug didn’t cause the disease, a witness testified. As early as 1999, Johnson & Johnson’s Janssen unit had researchers’ findings that about half the patients taking Risperdal in a study comparing its risks to those of Eli […]
Read More »Category : News
Bristol-Myers In Hot Water Over Boiled Monkey?
First, the monkey was in hot water. Now, the same may be said for Bristol-Myers Squibb. The drugmaker accidentally killed a crab-eating macaque last summer when its cage was being sanitized, but the primate remained locked inside, according to an inspection report by the US Department of Agriculture. The monkey died at a Bristol-Myers lab […]
Read More »Category : News
Novartis Reverses Plant Closure In Switzerland
Nearly three months of sustained pressure has prompted Novartis to change its corporate mind and abandon plans to close a plant in Vaud, Switzerland, a step that will save about 320 jobs. At the same time, the drugmaker will elminate fewer than the 760 jobs that were originally to have been cut at a chemical […]
Read More »Category : News
Chef of Unhealthy Foods Is Now Spokesperson for Novo Nordisk
Meet the new face of diabetes. Yes, the self-styled Queen of Southern Cuisine, who is famous for her Food Network episodes where she serves up all manner of sugary, fried and all-around heavy eats, is now the new spokesperson for Novo Nordisk. Specifically, Paula is revealing her previously undisclosed tale as a Type 2 diabetes […]
Read More »Category : News
Takeda Plans To Cut 2,800 Jobs In US & Europe
Three months after completing its $13 billion acquisition of Nycomed, Takeda Pharmaceuticals now plans to cut roughly 10 percent of its workforce, or 2,800 jobs – about 2,100 from Europe and 700 from the US – by 2016 in order to save approximately $2.6 billion. The reorganization will include closing an unspecified number of sites […]
Read More »Category : News
Sanofi Chemist Admits To Stealing Trade Secrets
Yuan Li began was hired as a medicinal chemist for Sanofi nearly six years ago. During that time, she worked on countless compounds and signed all the usual paperwork in which she acknowledged there were no conflicts of interest and that the intellectual property belonged to the drugmaker. But last year, Sanofi learned otherwise. In […]
Read More »Category : News
